Johanna Friedl-Naderer

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Ron Caponigro, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Johanna Friedl-Naderer:

Company Role Class Num Shares Value Price $ Report Date Ownership
Dyne Therapeutics, Inc. Chief Commercial Officer Common Stock 154,581 $2,303,256 $14.90 05 Mar 2026 Direct
Vir Biotechnology, Inc. EVP & Chief Operating Officer Common Stock 148,518 $227,233 $1.53 03 Mar 2023 Direct
Dyne Therapeutics, Inc. Chief Commercial Officer Stock option (right to buy) 90,000 12 Feb 2026 Direct

Insider Reports Filed by Johanna Friedl-Naderer

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DYN Dyne Therapeutics, Inc. 05 Mar 2026 1 -$2,205 4 Chief Commercial Officer 06 Mar 2026, 16:10
DYN Dyne Therapeutics, Inc. 12 Feb 2026 2 $0 4 Chief Commercial Officer 17 Feb 2026, 17:09
DYN Dyne Therapeutics, Inc. 05 Dec 2025 1 -$2,984 4 Chief Commercial Officer 05 Dec 2025, 16:08
DYN Dyne Therapeutics, Inc. 04 Sep 2025 2 -$13,794 4 Chief Commercial Officer 08 Sep 2025, 16:06
DYN Dyne Therapeutics, Inc. 16 Jul 2025 1 $0 4 Chief Commercial Officer 18 Jul 2025, 17:21
DYN Dyne Therapeutics, Inc. 05 Jun 2025 1 -$1,949 4 Chief Commercial Officer 06 Jun 2025, 16:03
DYN Dyne Therapeutics, Inc. 13 Mar 2025 1 -$1,733 4 Chief Commercial Officer 13 Mar 2025, 16:13
DYN Dyne Therapeutics, Inc. 04 Dec 2024 2 $0 4 Chief Commercial Officer 06 Dec 2024, 16:05
DYN Dyne Therapeutics, Inc. 03 Sep 2024 0 $0 3 Chief Commercial Officer 03 Sep 2024, 18:20
DYN Dyne Therapeutics, Inc. 03 Sep 2024 2 $0 4 Chief Commercial Officer 03 Sep 2024, 18:16
VIR Vir Biotechnology, Inc. 03 Mar 2023 1 -$33,819 4 EVP & Chief Operating Officer 07 Mar 2023, 13:04
VIR Vir Biotechnology, Inc. 22 Feb 2023 2 $0 4 EVP & Chief Operating Officer 24 Feb 2023, 19:27
VIR Vir Biotechnology, Inc. 02 Mar 2022 2 $0 4 Chief Business Officer, Global 08 Mar 2022, 10:35
VIR Vir Biotechnology, Inc. 02 Mar 2022 0 $0 3 Chief Business Officer, Global 08 Mar 2022, 10:33